Enteric fever, primarily caused by Salmonella Typhi and Paratyphi, continues to pose significant health challenges globally. Despite advancements in diagnostic technology and therapeutics, the disease remains a major cause of morbidity and mortality in developing countries. This article provides an updated approach to the diagnosis and management of enteric fever, targeting healthcare professionals.
Early diagnosis of enteric fever is crucial for effective management. Culturing of blood and bone marrow remains the gold standard for diagnosis. However, these methods are time-consuming and may yield false negatives. Recent advancements include molecular methods such as PCR and serological tests like Typhidot and Tubex. These rapid diagnostic tests, although not as sensitive as culture methods, provide quicker results and are especially useful in resource-limited settings.
Antibiotic therapy is the cornerstone of enteric fever management. Historically, chloramphenicol, ampicillin, and cotrimoxazole were the drugs of choice. However, due to increasing drug resistance, fluoroquinolones became the preferred treatment. Unfortunately, resistance to these drugs is also emerging. Third-generation cephalosporins and azithromycin are now the recommended first-line treatments. It is essential to monitor local antimicrobial resistance patterns and adjust treatment accordingly.
Vaccination can play a significant role in preventing enteric fever. Two vaccines are currently available: the oral live attenuated Ty21a vaccine and the injectable Vi polysaccharide vaccine. Both vaccines have demonstrated moderate efficacy and are recommended for travelers to endemic areas and high-risk populations. Hand hygiene, safe food practices, and clean water supply remain critical for prevention.
Enteric fever continues to be a significant health burden, particularly in resource-poor settings. Early diagnosis and appropriate antibiotic treatment are crucial for effective disease management. In the face of growing antimicrobial resistance, the importance of vaccination and preventive measures cannot be overstated. Healthcare professionals must stay updated with the latest diagnostic and therapeutic advancements to combat this persistent disease effectively.
1.
Tumor characteristics found to differ for melanomas in children, teens and young adults
2.
Unexplained CAR-T Death; Americans Spurn Sunscreen; Improving Diversity in Trials
3.
"A lot" of aspirin reduces the risk of ovarian cancer, regardless of genetic factors, according to the JAMA study.
4.
Approval in Endometrial Cancer Expanded; Masks at Cancer Centers; NPR Reporter Dies
5.
Is Lenalidomide Resistance in Myeloma Reversible with JAK Inhibition?
1.
Modern Oncology Unveiled with Treatment Innovations and Personalized Cancer Care
2.
Screening for Early Therapy-Related Cancer Susceptibility
3.
Unlocking the Potential of Bicalutamide 50 mg: A Revolutionary New Treatment for Prostate Cancer
4.
Skin-Sparing Mastectomy: Balancing Cancer Control with Cosmetic Results
5.
Reducing Modifiable Childhood Cancer Exposure Risks
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
2.
Targeting Oncologic Drivers with Dacomitinib: Further Discussion on Lung Cancer Treatment
3.
Should We Use DARA Up Front As First-Line Therapy in MM?
4.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option- A New Perspective
5.
Importance of Cancer Screening and Early Detection
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation